←
Parul Tandon DO PhD FRCPC934 posts
Parul Tandon DO PhD FRCPC avatar

Parul Tandon DO PhD FRCPC

@ptandonGI

"IBDologist", Clinician Scientist @UHN, Assistant Prof @UofT, @UofTGastroHep alum, @SinaiHealth IBD alumni, PhD Clin Epi @ihpmeuoft; lucky husband and father!

◷ Joined November 2018▧ 52 Photos and videos
CGH avatar
⟳ Parul Tandon DO PhD FRCPC retweeted
CGH@AGA_CGH·Nov 13

In a large, diverse, contemporary cohort of US adults newly diagnosed with IBD, there has been significant increase in early use of advanced therapies and decline in excess use of corticosteroids. 🔗: ow.ly/35j95105uPY

Post attachment
Parul Tandon DO PhD FRCPC avatar
Parul Tandon DO PhD FRCPC@ptandonGI·May 15

Immigrants living with #IBD face major barriers to care, including language discordance, lack of translation services, and difficulty attending appointments. Call for action to improve access to IBD care for all! @CGafrey @JCanAssnGastro academic.oup.com/jcag/articl…

The Canadian IBD Research Consortium (CIRC) avatar
⟳ Parul Tandon DO PhD FRCPC retweeted
The Canadian IBD Research Consortium (CIRC)@CIRC_CCRM·May 14

Junior CIRC Member Spotlight! @ptandonGI is a clinician scientist at the University Health Network and assistant professor at U of T. His research program focuses on IBD care of racial and ethnic minorities, and providing equitable care to all living with this chronic disease.

Post attachment
Tauseef Ali MD, FACG AGAF FACP avatar
⟳ Parul Tandon DO PhD FRCPC retweeted
Tauseef Ali MD, FACG AGAF FACP@ibdtweets·May 10

One of the most fascinating developments in IBD care is the ongoing evolution of our definition of “remission.” This conceptual infographic visualizes the evolving continuum of remission and healing in IBD. ⚠️ Importantly, this is an educational and conceptual framework reflecting emerging ideas in the field and is not yet validated or endorsed by expert consensus societies. linkedin.com/posts/one-of-th…

Parul Tandon DO PhD FRCPC avatar
Parul Tandon DO PhD FRCPC@ptandonGI·May 4

New Podcast Alert! Here the famous Dr. Fung discuss all things MASLD! @TLC_LiverCure @UofT_DoM @AASLDtweets @UHN @UofTGastroHep

Hope everyone is enjoying @DDWMeeting! If you’re looking for something to listen to on your travels come check out our chat with Dr. Scott Fung, a leading expert in Hepatology @UofTGastroHep @UHN, on all things metabolic liver disease! We cover diagnosis, tx, future directions

Post attachmentPost attachment
Neeraj Narula avatar
⟳ Parul Tandon DO PhD FRCPC retweeted
Neeraj Narula@NarulaNeeraj·May 3

Dr. Sanjay Murthy presents the IBD-Dysplasia study at #DDW2026 demonstrating no incremental benefit of random biopsies during IBD surveillance colonoscopy. Great to see this Canadian collaboration with over 1400 pts included! @CIRC_CCRM

Post attachment
Parul Tandon DO PhD FRCPC avatar
Parul Tandon DO PhD FRCPC@ptandonGI·Apr 24

🎉 Excited to co-host the 2nd annual 2026 Toronto IBD Research Symposium (Apr 24th, 26) @UHN @BMOEdConfCentre. Highlighting cutting-edge IBD research:📷 Preclinical CD | 📷 Novel Imaging (IUS) | 📷 Special Populations | 📷 EIMs 📷 Big Data 📷 Nutrition and Surgical Advances

Post attachmentPost attachment
MCIBD avatar
⟳ Parul Tandon DO PhD FRCPC retweeted
MCIBD@MCIBD_Can·20 Dec 2025

ATTN Clinicans who care for #IBD patients‼️Join us for Multidisciplinary Care in IBD on April 11, 2026! Discussions from fertility to pregnancy & post partum, surrounding management of IBD & immune mediated inflammatory diseases @ScopeCanMD REGISTER HERE: mcibdregister.ca

Post attachment
Parul Tandon DO PhD FRCPC avatar
Parul Tandon DO PhD FRCPC@ptandonGI·10 Nov 2025

Our recent SRMA looks at impact of #IBD therapies on bowel urgency, with all therapies improving BU significantly compared to placebo (some as soon as 48hrs after start of therapy) onlinelibrary.wiley.com/doi/… @vipuljairath @NarulaNeeraj @DrLexGI Chris Ma (@CalgaryIBD)